Carus Animal Health and Fixed Phage to collaborate on anti-bacterial solutions to companion animal diseases

Carus Animal Health and British biotechnology company, Fixed Phage, have agreed a strategic collaboration in the companion animal field to identify, develop and commercialise stable and specific bacteriophages and their application through its patented technology. The focus of the new arrangement will be the use of Fixed Phage technology which provides the opportunity to deploy […]

Continue Reading

Carus Animal Health announces double acquisition, bringing together ‘best-in-class’ veterinary technologies

Carus Animal Health has announced the acquisition of ‘software as a service’ company Medi-Productions and veterinary data provider, Veterinary Insights (along with its French division DBM). The new partnership will combine Medi-Productions’ one-of-a-kind veterinary virtual and augmented reality technology and Veterinary Insight’s unique veterinary data capabilities, to position Carus Animal Health as a vet tech […]

Continue Reading

Carus Animal Health and Intract Pharma enter agreement to develop novel drug delivery technology

Carus Animal Health and Intract Pharma have entered into an agreement to utilise Intract’s novel drug delivery technologies for applications in the veterinary market for companion animals. Intract Pharma Ltd, a UK company specialising in the development of oral drug formulations has developed unique models and proprietary drug delivery technologies to develop advanced new products […]

Continue Reading